• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Progen Pharmaceuticals Ltd

+ Add to Watchlist

PG1:GR

0.779 EUR 0.014 1.77%

As of 12:05:40 ET on 07/25/2014.

Snapshot for Progen Pharmaceuticals Ltd (PG1)

Open: 0.778 Day's Range: 0.717 - 0.779 Volume: 300
Previous Close: 0.793 52wk Range: 0.084 - 0.869 1-Yr Rtn: +827.38%

Stock Chart for PG1

No chart data available.
  • PG1:GR 0.779
  • 1D
  • 1M
  • 1Y
0.793
Interactive PG1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PG1

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 43.07
Shares Outstanding (M) 55.29
30 Day Average Volume 207
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PG1

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PG1

Progen Pharmaceuticals Limited is involved in the discovery, research and development of potential biopharmaceutical therapeutics for the treatment of human diseases. The Company also provides contract services related to the process development, manufacture and quality assurance of biological products.

Indrajit Solomon Arulampalam "Jitto"ChairmanHeng Hsin TangActing Managing Director
Lee HorobinGen Mgr:FinanceFleur LankesheerDir:Bus Development & Legal
More Company Profile & Key Executives for PG1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil